Technology is based on the creation of RNA synthetic fragments that stimulate the body’s immune response to tumor cells. The vaccine has already been tested on animals and is now tested on volunteers.
The working principle of the vaccine is that scientists analyze the tumor genome of the patient, compare it with normal cells, and determine the areas where changes occur. Then, a MRNA that activates the immune system on the recognition and destruction of these changing cells is formed.
Professor Altstein stressed that the vaccine is not designed for cancer prevention, such as many familiar vaccines, but aims for treatment. It will be used to combat cancer at various stages, including remission, but only after the tumor is removed by surgical method. The vaccine will help prevent cancer from returning and stop the growth of the remaining tumor cells.
So far, the drug is subjected to the necessary tests and scientists claim that it is a long step to create an effective tool against cancer. In the future, they plan to give a free vaccination for patients.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
